Joseph Barritt

Dr. Joseph Barritt is a Research Associate in the Department of Life Sciences at Imperial College London’s Faculty of Natural Sciences. His research focuses on structural biology, neurodegenerative diseases, microbiology, and nanotechnology. He investigates protein-membrane interactions, viral replication mechanisms, and the structural basis of disease-related protein misfolding. His work spans Alzheimer’s disease, Parkinson’s disease, bacterial biofilm breakdown, and nanoparticle design for drug delivery.

Dr. Barritt’s expertise includes advanced analytical tools for studying membrane proteins and viral vectors. His recent projects include developing microfluidic platforms for nanoparticle synthesis and characterizing adenovirus-based vaccines. He collaborates on bacteriophage therapies targeting gut bacteria and structural studies of plant borate transporters.

While no scientific awards or grants are explicitly listed, his publications reflect interdisciplinary research at the intersection of biophysics, virology, and nanotechnology. He is affiliated with the Department of Life Sciences at Imperial College London, contributing to cutting-edge studies in structural biology and infectious diseases.